Serositis causing pericardial and pleural effusions after eight years of maintenance ibrutinib for Waldenstrom's macroglobulinemia

Autor: Grace Johnson, Niharika Baviriseaty, Nicholas Massanet, Jeffrey Kooper

Publikováno v: Journal of Oncology Pharmacy Practice. :107815522311719

Introduction Ibrutinib is a tyrosine kinase inhibitor approved for multiple B-cell malignancies, including Waldenstrom's macroglobulinemia in 2014. Although the drug portends favorable outcomes, it also bears a profile of side effects. Current litera

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::75088d7ef891ae10b0aff5d09a4bc031
https://doi.org/10.1177/10781552231171925

Scientific Session of the 16th World Congress of Endoscopic Surgery, Jointly Hosted by Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) & Canadian Association of General Surgeons (CAGS), Seattle, Washington, USA, 11-14 April 2018: Podium Abstracts.

Publikováno v: Surgical Endoscopy & Other Interventional Techniques; Apr2018 Supplement, Vol. 32, p1-44, 44p, 5 Color Photographs, 1 Black and White Photograph, 1 Diagram, 37 Charts, 7 Graphs